Sociodemographic, clinical and pharmacological characteristics of older adults with fractures, in three reference centers, Colombia
DOI:
https://doi.org/10.21615/cesmedicina.34.1.2Keywords:
Fractures bone, Hip fractures, Osteoporosis, Aged, PharmacoepidemiologyAbstract
Introduction: Falls and bone fractures are important causes of morbidity and mortality in the elderly. Its etiology is multicausal, including inadequate prescriptions and osteoporosis. The aim was to identify the clinical and pharmacological characteristics of a group of older adults diagnosed with fractures in Colombia. Methods: Cross-sectional study that analyzed the prescriptions made one month before the fracture, during hospitalization and discharge. Patients aged 60 years and over were selected, assisted in three reference centers in Colombia. The quality of the prescriptions was analyzed using the STOPP criteria. Results: 220 pa-tients with fractures were included, with a mean age of 75.3±10.3 years and 68.2 % were women. Hip fracture was the most frequent (37.7 %) and in-hospital mortality was 2.3 %. Prescription of calcium/vitamin D supplements and antiabsortive therapy at discharge was 23.7 % and 12.1 %, respectively. Prescriptions potentially inappropriate to discharge were identified in 11.6 % of patients and having five or more comorbidities was associated with greater probability of having them (OR:9.44, 95 % CI: 2.16-41.20). Conclusions: Medical staff generally do not formulate antiosteporotic medications as secondary prevention or improve the quality of prescriptions for fractured pa-tients once they are hospitalized and discharged, so it is necessary to develop phar-macological strategies to help prevent new episodes of falls and fractures.
Downloads
References
Rodrigues MC, Oliveira Cd. Drug-drug interactions and adverse drug reactions in polypharmacy among older adults: an integrative review. Rev Lat Am Enfermagem. 2016;24:e2800.
Departamento Administrativo Nacional de Estadística de Colombia (DANE). Censo general 2005 [internet]. [Consultado: 25 de Diciembre 2017]. Disponible en: http://www.dane.gov.co/files/censoslibroCenso2005nacional.pdf.
Gonzáles I, Becerra M, Gónzales J, Campos A, Barbosa J, Alvarado J. Fracturas de cadera: satisfacción posquirúrgica al año en adultos mayores atendidos en Méderi-Hospital Universitario Mayor, Bogotá, D.C. Rev Cienc Salud. 2015;14(3):409-22.
Davies EA, O'Mahony MS. Adverse drug reactions in special populations – the elderly. Br J Clin Pharmacol. 2015;80(4):796-807.
Kim J, Parish AL. Polypharmacy and Medication Management in Older Adults. Nurs Clin North Am. 2017;52(3):457-468.
Court-Brown CM, McQueen MM. Global Forum: Fractures in the Elderly. J Bone Joint Surg Am. 2016;98(9):e36.
Lambert JK, Zaidi M, Mechanick JI. Male osteoporosis: epidemiology and the pathogenesis of aging bones. Curr Osteoporos Rep. 2011;9(4):229-36.
Berry SD, Miller R. Falls: Epidemiology, Pathophysiology, and Relationship to Fracture. Current osteoporosis reports. 2008;6(4):149-54.
Park H, Satoh H, Miki A, Maki H, Asai K, Shiraishi A, Urushihara H, Sawada Y. Medications and fall risk: a case-control study in nursing home residents in
Japan. Aging Clin Exp Res. 2019 Jul 17. doi: 10.1007/s40520-019-01265-9. [Epub ahead of print].
Verdoorn S, Kwint HF, Faber A, Gussekloo J, Bouvy ML. Majority of drug-related problems identified during medication review are not associated with STOPP/START criteria. Eur J Clin Pharmacol. 2015;71(10):1255-62.
Storms H, Marquet K, Aertgeerts B, Claes N. Prevalence of inappropriate medication use in residential long-term care facilities for the elderly: A systematic review. Eur J Gen Pract. 2017;23(1):69-77.
Cano-Guitierrez C, Samper-Ternent R, Cabrera J, Rosselli D. [Medication use among older adults in Bogota, Colombia]. Rev Peru Med Exp Salud Publica. 2016; 33(3):419-424.
Machado-Duque M, Castro-Rodriguez A, Medina-Morales D, Machado-Alba J. Identification of Potentially Inappropriate Cardiovascular Prescriptions in the Elderly Using Beers Criteria in Colombia. Value in Health. 2018;21:S96.
Valladales-Restrepo LF, Duran-Lengua M, Machado-Alba JE. Potentially inappropriate prescriptions of anticholinergics drugs in Alzheimer's disease patients. Geriatr Gerontol Int. 2019;19(9):913-917.
Zia A, Kamaruzzaman SB, Tan MP. The consumption of two or more fall risk-increasing drugs rather than polypharmacy is associated with falls. Geriatr Gerontol Int. 2017;17(3):463-470.
Aguilar Del Rey FJ, Pérez González O. Epidemiology of osteoporotic fractures in Andalusia, Spain, from 2000-2010. Med Clin (Barc). 2018;150(8):297-302.
Liu SK, Munson JC, Bell JE, Zaha RL, Mecchella JN, Tosteson AN, Morden NE. Quality of osteoporosis care of older Medicare recipients with fragility fractures: 2006 to 2010. J Am Geriatr Soc. 2013;61(11):1855-62.
Roux S, Cabana F, Carrier N, Beaulieu M, April PM, Beaulieu MC, Boire G. The World Health Organization Fracture Risk Assessment Tool (FRAX) underestimates incident and recurrent fractures in consecutive patients with fragility fractures. J Clin Endocrinol Metab. 2014;99(7):2400-8.
Hernlund E, Svedbom A, Ivergård M, Compston J, Cooper C, Stenmark J, McCloskey EV, Jönsson B, Kanis JA. Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA). Arch Osteoporos. 2013;8:136.
Tran T, Bliuc D, van Geel T, Adachi JD, Berger C, van den Bergh J, Eisman JA, Geusens P, Goltzman D, Hanley DA, Josse RG, Kaiser SM, Kovacs CS, Langsetmo L, Prior JC, Nguyen TV, Center JR. Population-Wide Impact of Non-Hip Non-Vertebral Fractures on Mortality. J Bone Miner Res. 2017;32(9):1802-1810.
Desai RJ, Mahesri M, Abdia Y, Barberio J, Tong A, Zhang D, Mavros P, Kim SC, Franklin JM. Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis. JAMA Netw Open. 2018;1(3):e180826.
Dovjak P. [Diagnostics and treatment of osteoporosis in patients over 65 years old: Current status and future perspectives]. Z Gerontol Geriatr. 2019;52(5):421-427
Narla RR, Hirano LA, Lo SHY, Anawalt BD, Phelan EA, Matsumoto AM. Suboptimal osteoporosis evaluation and treatment in older men with and without additional high-risk factors for fractures. J Investig Med. 2019;67(4):743-749.
Haentjens P, Autier P, Collins J, Velkeniers B, Vanderschueren D, Boonen S. Colles fracture, spine fracture, and subsequent risk of hip fracture in men and women. A meta-analysis. J Bone Joint Surg Am. 2003;85(10):1936-43.
Perng HJ, Chiu YL, Chung CH, Kao S, Chien WC. Fall and risk factors for veterans and non-veterans inpatients over the age of 65 years: 14 years of long-term data analysis. BMJ open. 2019;9(8):e030650.
Bromfield SG, Ngameni CA, Colantonio LD, Bowling CB, Shimbo D, Reynolds K, Safford MM, Banach M, Toth PP, Muntner P. Blood Pressure, Antihypertensive Polypharmacy, Frailty, and Risk for Serious Fall Injuries Among Older Treated Adults With Hypertension. Hypertension. 2017;70(2):259-266.
Margolis KL, Buchner DM, LaMonte MJ, Zhang Y, Di C, Rillamas-Sun E, Hunt J, Ikramuddin F, Li W, Marshall S, Rosenberg D, Stefanick ML, Wallace R, LaCroix AZ. Hypertension Treatment and Control and Risk of Falls in Older Women. J Am Geriatr Soc. 2019;67(4):726-733.
Yang Y, Hu X, Zhang Q, Zou R. Diabetes mellitus and risk of falls in older adults: a systematic review and meta-analysis. Age Ageing. 2016;45(6):761-767.
Neila Calvo S, Nan Nan D, García Ibarbia C, Olmos Martínez JM, González Macías J, Hernández Hernández JL. La realidad de la osteoporosis en el paciente hospitalizado en Medicina Interna. Revista de Osteoporosis y Metabolismo Mineral. 2013;5:141-5.
Cerocchi I, Ghera S, Gasbarra E, Scialdoni A, Tarantino U. Fragility fractures: the clinical pathway. Aging Clin Exp Res. 2013;25 Suppl 1:S43-5.
Milat F, Ebeling PR. Osteoporosis treatment: a missed opportunity. Med J Aust. 2016;205(4):185-90.
Tang BM, Eslick GD, Nowson C, Smith C, Bensoussan A. Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis. Lancet. 2007;370(9588):657-66.
Flais J, Coiffier G, Le Noach J, Albert JD, Faccin M, Perdriger A, Thomazeau H, Guggenbuhl P. Low prevalence of osteoporosis treatment in patients with recurrent major osteoporotic fracture. Arch Osteoporos. 2017;12(1):24.
Kim SC, Kim MS, Sanfélix-Gimeno G, Song HJ, Liu J, Hurtado I, Peiró S, Lee J, Choi NK, Park BJ, Avorn J. Use of osteoporosis medications after hospitalization for hip fracture: a cross-national study. Am J Med. 2015 May;128(5):519-26.e1.
Tinetti ME, Kumar C. The patient who falls: "It's always a trade-off". JAMA. 2010;303(3):258-66.
Rubenstein LZ. Falls in older people: epidemiology, risk factors and strategies for prevention. Age Ageing. 2006;35 Suppl 2:ii37-ii41.
Rubenstein LZ, Josephson KR. Falls and their prevention in elderly people: what does the evidence show? Med Clin North Am. 2006;90(5):807-24.
Belfrage B, Koldestam A, Sjöberg C, Wallerstedt SM. Number of drugs in the medication list as an indicator of prescribing quality: a validation study of polypharmacy indicators in older hip fracture patients. Eur J Clin Pharmacol. 2015;71(3):363-8.
Lönnbro J, Wallerstedt SM. Clinical relevance of the STOPP/START criteria in hip fracture patients. Eur J Clin Pharmacol. 2017;73(4):499-505.
Gosch M, Wörtz M, Nicholas JA, Doshi HK, Kammerlander C, Lechleitner M. Inappropriate prescribing as a predictor for long-term mortality after hip fracture. Gerontology. 2014;60(2):114-22.
Machado-Alba JE, Gaviria-Mendoza A, Machado-Duque ME, Chica L. Deprescribing: a new goal focused on the patient. Expert Opin Drug Saf. 2017;16(2):111-112.
Machado-Duque ME, Castaño-Montoya JP, Medina-Morales DA, Castro-Rodríguez A, González-Montoya A, Machado-Alba JE. Association between the use of benzodiazepines and opioids with the risk of falls and hip fractures in older adults. Int Psychogeriatr. 2018;30(7):941-946.
Machado-Duque ME, Castaño-Montoya JP, Medina-Morales DA, Castro-Rodríguez A, González-Montoya A, Machado-Alba JE. Drugs With Anticholinergic Potential and Risk of Falls With Hip Fracture in the Elderly Patients: A Case-Control Study. J Geriatr Psychiatry Neurol. 2018;31(2):63-69
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2020 CES Medicina
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Derechos de reproducción (copyright)
Cada manuscrito se acompañará de una declaración en la que se especifique que los materiales son inéditos, que no han sido publicados anteriormente en formato impreso o electrónico y que no se presentarán a ningún otro medio antes de conocer la decisión de la revista. En todo caso, cualquier publicación anterior, sea en forma impresa o electrónica, deberá darse a conocer a la redacción por escrito.
Plagios, duplicaciones totales o parciales, traduccones del original a otro idioma son de responsabilidad exclusiva de los autores el envío.
Los autores adjuntarán una declaración firmada indicando que, si el manuscrito se acepta para su publicación, los derechos de reproducción son propiedad exclusiva de la Revista CES Medicina.
Se solicita a los autores que proporcionen la información completa acerca de cualquier beca o subvención recibida de una entidad comercial u otro grupo con intereses privados, u otro organismo, para costear parcial o totalmente el trabajo en que se basa el artículo.
Los autores tienen la responsabilidad de obtener los permisos necesarios para reproducir cualquier material protegido por derechos de reproducción. El manuscrito se acompañará de la carta original que otorgue ese permiso y en ella debe especificarse con exactitud el número del cuadro o figura o el texto exacto que se citará y cómo se usará, así como la referencia bibliográfica completa.
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
